On July 28 Community Voices for 340B submitted a response to Senators Thune, Stabenow, Capito, Baldwin, Moran, and Cardin’s request for information on the 340B Drug Discount Program. CV340B conducted independent analysis of the publicly available HRSA audit reports finding that covered entity compliance with the 340B program has improved by 41% over the past…
DetailsProviders March to Capitol Hill for Second Straight Year to ‘Defend 340B’ July 13, 2023 William Newton Read the full article: Providers March to Capitol Hill for Second Straight Year to Defend 340B reprint excerpt. Excerpted by Permission of 340B Report. On a sunny, humid, 92-degree afternoon in Washington, D.C., over 50 safety- net…
DetailsCV340B’s Northeast Regional Advocacy Group is hosting a webinar titled ‘340B in the Northeast’ scheduled for 11:00am- 12:00pm on Tuesday May 25th, 2021. Webinar will include a brief history of the 340B Drug Pricing Program, current threats to the program, a panel of Northeastern providers and a discussion on advocacy. The panel will discuss how…
DetailsIn this webinar sponsored by CV-340B, our panel of four exceptional leaders at the forefront of 340B will discuss the impact of women in 340B. The speakers will dive into the program’s history, the amazing women who are currently shaping the program, and why 340B disproportionately impacts women as beneficiaries. Tuesday, March 30th, 3:00 pm-4:00…
DetailsMarch 2, 2021 PRESS STATEMENT: FOR IMMEDIATE RELEASE Contact: Peggy.Tighe@PowersLaw.com CV340B Names Advisory Council – Prominent 340B Leaders Join National Efforts to Educate, Enable, and Inspire Support for the 340B Drug Pricing Program Today, Community Voices for 340B (CV340B) announced the appointment of seven leaders who have long served safety net providers participating…
DetailsThrough unprecedented attacks on the 340B drug discount program in 2020, CV340B has advocated for 340B’s protection in the community. On December 30th, 2020 Community Voices for 340B sent a letter outlining our work to President-Elect Biden’s transition team. CV340B received a positive response and looks forward to working with the new administration in 2021.…
Details
